Pure-play MEMS foundry Silex sets price for its IPO in Stockholm.

      The Bure Equity- and Creades-supported pure-play MEMS foundry was priced at SEK 81 per share, with the offering being oversubscribed multiple times. Key cornerstone investors like Capital Research, Fidelity, AFA, AP2, AP3, AP4, Swedbank Robur, and Carnegie accounted for roughly three-quarters of the offering.

      On its Nasdaq Stockholm debut on Wednesday, Silex Microsystems saw a strong initial surge in share price, with the chipmaker's stocks rising following the IPO pricing of SEK 81. The offering had received several times the subscription amount during the bookbuild phase and was primarily allocated to institutional cornerstones, resulting in limited availability for retail investors on the opening day.

      The deal generated about SEK 1.99 billion ($217 million) from a 24.6-million-share offering, leading to an equity valuation of around SEK 8.9 billion at the time of the IPO. Its trading symbol is SILEX, and the settlement date is set for May 11.

      Silex positions itself as the leading pure-play MEMS foundry globally, producing micro-electromechanical systems for sectors such as automotive, industrial, life sciences, and consumer electronics, all from a single facility in Järfälla, near Stockholm, utilizing 200mm wafer production. The pure-play model indicates that Silex manufactures chips based on designs from other companies, analogous to TSMC's relationships with fabless semiconductor designers but within the much smaller MEMS market.

      The financials associated with the listing are particularly strong for a recent European chip IPO. For the fiscal year ending December 31, 2025, net sales reached SEK 1,385 million, with an EBIT of SEK 368 million, resulting in an operating margin of about 27%. The first quarter of 2026 showed even stronger performance, with revenues of SEK 375 million and an EBIT of SEK 128 million, representing an operating margin exceeding 34%. Such figures are appealing to the institutional cornerstone investors who largely funded the deal.

      The cornerstone participants significantly influence the expected trading dynamics of the stock. These investors collectively acquired ordinary shares valued at around SEK 1.501 billion, constituting roughly 75% of the offering. The investor list includes Creades, AFA Insurance, Tredje AP-fonden, Capital Research Global Investors, Swedbank Robur Fonder, Fjärde AP-fonden, Andra AP-fonden, Fidelity International, and Carnegie Fonder.

      This diverse mix of three Swedish national pension funds, two of the largest fund managers in Sweden, two significant US institutional investors, and Sweden’s largest insurance company creates an unusually robust cornerstone backing for a Stockholm-based chip listing.

      Post-IPO, ownership remains concentrated, with Bure Equity retaining about 34.2% of the ordinary shares and Creades holding approximately 10.1%. These two firms were key in the original investor group that purchased Silex from its prior Chinese-state-aligned owner in 2023, restoring Swedish ownership after nearly seven years under Sai MicroElectronics.

      This ownership shift is an important backdrop: Silex operated as a Swedish fab within a Chinese-controlled corporate structure during the latter part of the 2010s, until the geopolitical changes in 2022 and 2023 rendered that arrangement untenable both commercially and politically.

      The MEMS market has been expanding driven by AI-related demand. Recent contracts encompass a large-scale manufacturing partnership with Norwegian audio specialist sensiBel for high-quality MEMS microphones, a sector where processor demand is being fueled by on-device AI workloads permeating the broader semiconductor industry.

      Silex's client portfolio spans multiple end-markets, but the demand trends supporting global foundry capacity increases are also why a pure-play MEMS operator can successfully conduct an IPO in Stockholm at this valuation.

      Two questions remain unanswered in the public domain. First, the extent of the share price increase on opening day; while Bloomberg reported a surge, the exact percentage has not yet been disclosed in subsequent analyses. Secondly, the intended use of the IPO funds by Silex is unclear.

      The prospectus suggests that the funds will be allocated for capacity expansion at the Järfälla facility and for enhancing balance-sheet flexibility to facilitate selective acquisitions within the MEMS supply chain. Investors will be keenly observing whether the company can effectively utilize the capital in line with the broader AI-driven demand cycle in its upcoming quarterly reports.

      For the time being, the listing has achieved its goals. Silex has established a public-market valuation near SEK 8.9 billion in enterprise value, attracted a substantial pool of cornerstone investors, and offered Bure Equity and Creades a partial avenue for monetization while retaining a controlling combined stake. The next significant event will be the Q2 earnings report, marking Silex’s first reporting cycle as a publicly traded entity.